Ro10-5824
Ro10-5824 is a drug that acts as a dopamine D4 receptor partial agonist. It has been researched for its potential use in the treatment of schizophrenia and Parkinson's disease, but has not been developed for medical use.
Pharmacology[edit | edit source]
Ro10-5824 is a partial agonist at the D4 subtype of the dopamine receptor family. This means it can both activate the receptor to produce a response, and also block the receptor to prevent other molecules from activating it. This dual action can make it useful in conditions where the dopamine system is overactive, such as schizophrenia, or underactive, such as Parkinson's disease.
Potential Medical Uses[edit | edit source]
Ro10-5824 has been researched for its potential use in the treatment of schizophrenia and Parkinson's disease. In preclinical studies, it has shown promise in reducing the symptoms of these conditions. However, it has not been developed for medical use, and further research is needed to determine its safety and efficacy in humans.
See Also[edit | edit source]
References[edit | edit source]
Ro10-5824 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD